InvestSMART

EMvision Medical Devices Limited (ASX: EMV) - Share Price

- Current share price for EMV : $1.420

EMVision Medical Devices Limited (EMV) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is an Australian medical device company developing a novel approach to looking inside the human body. Its product pipeline includes portable, non-invasive, non-ionizing, affordable and safe neurodiagnostic devices.

EMV General Information +

ASX Code EMV
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) 131
EMV Share Price $1.420
Day High $1.425
Day Low $1.365
Last Close $1.420
EMV Share Price Movement - ( No change )
Prices as at 16:40, 20 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

EMvision Medical Devices Limited (EMV) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from EMvision Medical Devices Limited (EMV) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

EMvision Medical Devices Limited (EMV) price-sensitive announcements

EMV - New $3m Grant Unlocks Traumatic Brain Injury Opportunity
EMVision Medical Devices Limited announced it had been awarded a new $3 million non-diluti
EMvision Medical Devices Limited (EMV)
20 Nov 2026 | 8:21 AM
EMV - Emu Regional Benefits CRCP Progress Payment Received
EMVision Medical Devices Limited announced it has received a Cooperative Research Centres
EMvision Medical Devices Limited (EMV)
18 Nov 2026 | 8:40 AM
EMV - Quarterly Activities/Appendix 4C Cash Flow Report
EMVision Medical Devices Ltd’s Appendix 4C and Quarterly Activities & Cashflow Report for
EMvision Medical Devices Limited (EMV)
26 Oct 2026 | 8:53 AM
EMV - $4.3m Non-Dilutive R&D Tax Rebate Received
EMVision Medical Devices Limited (ASX: EMV) announced it has received a $4.3 million cash
EMvision Medical Devices Limited (EMV)
28 Sep 2026 | 8:45 AM

EMvision Medical Devices Limited (EMV) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
EMvision Medical Devices Limited (EMV)
ORDINARY FULLY PAID
Health Care $132 New $3m Grant Unlocks Traumatic Brain Injury Opportunity 20 Nov 2026 8:21AM $1.420 $1.420 fallen by 0%
EMvision Medical Devices Limited (EMV)
ORDINARY FULLY PAID
Health Care $132 Emu Regional Benefits CRCP Progress Payment Received 18 Nov 2026 8:40AM $1.495 $1.420 fallen by 5.02%
EMvision Medical Devices Limited (EMV)
ORDINARY FULLY PAID
Health Care $132 Bell Potter Healthcare Conference Presentation 17 Nov 2026 9:04AM $1.445 $1.420 fallen by 1.73%
EMvision Medical Devices Limited (EMV)
ORDINARY FULLY PAID
Health Care $132 Quarterly Activities/Appendix 4C Cash Flow Report 26 Oct 2026 8:53AM $1.460 $1.420 fallen by 2.74%
EMvision Medical Devices Limited (EMV)
ORDINARY FULLY PAID
Health Care $132 Notice of Annual General Meeting/Proxy Form 23 Oct 2026 8:18AM $1.525 $1.420 fallen by 6.89%
EMvision Medical Devices Limited (EMV)
ORDINARY FULLY PAID
Health Care $132 Mayo Clinic emu Early Clinical Experience Presentation 19 Oct 2026 8:09AM $1.610 $1.420 fallen by 11.80%

EMV Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$8.32 -$9.10 -20.50% 0.00 0.00 0.00% 0.0%
2025A -$9.81 -$11.50 238.60% 0.00 0.00 0.00% 0.0%
2024A -$2.73 -$3.40 -31.90% 0.00 0.00 0.00% 0.0%

EMV Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
Cochlear Limited (COH) $10,063M -0.3136 0.2540 0.0785 37.4607 29.8730 27.6989 2.24% 2.33% 2.53%
EMvision Medical Devices Limited (EMV) $132M -0.2047 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Fisher & Paykel Healthcare Corporation Limited (FPH) $23,889M 0.1388 0.1474 0.1575 61.4093 53.5187 46.2370 1.07% 1.16% 1.29%
Imricor Medical Systems Inc (IMR) $470M -0.4254 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed Inc. (RMD) $20,370M 9.5922 0.1126 0.0881 23.6413 21.2489 19.5280 0.98% 1.04% 1.12%

EMV Directors

Name Position Start Date
Mr Scott Kirkland Co-founder, Executive Director, Chief Executive Officer, Managing Director 11 Jul 2017
Mr John Keep Non-Executive Chairman, Non-Executive Director 2 Mar 2018
Dr Phillip James Dubois Non-Executive Director 29 Sep 2020
Mr Anthony (Tony) Keane Non-Executive Director 29 Jun 2018
Mr Patryk Kania Non-Executive Director 7 Mar 2024
Ms Carmel Anne Monaghan Non-Executive Director 5 Jun 2025

EMvision Medical Devices Limited (EMV) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
22 Apr 2026 MONAGHAN, Carmel Buy Direct Shares 10,000 $1.847 $18,470.000
5 May 2023 WEINBERGER, Ronald (Ron) Exercise Options 223,602 $5.590 $1,250,000.000
5 May 2023 WEINBERGER, Ronald (Ron) Buy Direct Shares 223,602 $5.590 $1,250,000.000

See all changes in directors' interest & trades for EMvision Medical Devices Limited (EMV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EMV Management

Name Position
Emma Waldon Company Secretary

EMV Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EMvision Medical Devices Limited (EMV). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
8,143,624 (8.76%) Keysight Technologies, Inc

EMV Calendar of Events

Date Event
23 August 2027 Report (Annual)
23 August 2027 Report (Prelim)
22 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.